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Abstract:  
Hydrotropic solublization is new, simple, economic, safe method, can be used in analysis of drug. The use of various 
hydrotropes in place of organic solvents for the purpose of solubilization. Hydrotropes increases the solubility of organics 
in water. Objective of present investigation was to enhance the solubility of Itraconazole using the technique of 
hydrotropic solubilization technique and convert them into suitable oral liquid dosage form (suspension) useful for 
enhancement of bioavailability.0.5M, 1M, 2M of the hydrotropes (trisodium citrate, urea, sodium acetate, sodium 
benzoate and sodium salicylates) were used to study the saturation solubility. Solubility was found to be greater with 
trisodium citrate. Suspensions were prepared by using trisodium citrate solution, Itraconazole, xanthan gum, acacia, 
sodium alginate as a aqueous phase, dispersed phase and suspending agents respectively. Prepared suspensions were 
characterized for appearance of phases, particle size of dispersed Phase, pourability, sedimentation volume and in vitro 
drug release. All formulations of tri sodium citrate suspension were uniformly distributed, particle size of the dispersed 
phase was 10μm to 20μm, suspensions were easily pourable from the bottle and sedimentation volume in the rage of 0.5-1. 
More than 70% drug release was obtained at the end of the 45 minutes. Hydrotropic solubilization technique for 
preparation of suspensions of poor water soluble drugs will gave stability to the formulation and helps in enhancement of 
bioavailability of Itraconazole. 
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INTRODUCTION:  
Solubility is the major problem for various drugs in 
pharmaceutical industry. Many drugs show poor 
aqueous solubility, which result in poor 
bioavailability of the drug. Solubility enhancement 
processes are widely used in pharmaceutical industry 
to improve the dissolution and bioavailability of 
poorly water soluble drug. The efficacy of drug 
response is mainly dependent on dissolution and 
bioavailability. Almost more than 90% drugs are 
orally administered. Drug absorption, sufficient and 
reproducible bioavailability, pharmacokinetic profile 
of orally administered drug substance is highly 
dependent on solubility of that compound in aqueous 
medium. It is estimated that 40% of active new 
chemical entities identified by many pharmaceutical 
companies are poorly water soluble.  
 
Hydrotropy is a unique solubilization technique in 
which certain chemical compounds termed as 
hydrotropes can be used to affect a several 
fold increase in the aqueous solubility of sparingly 
soluble solutes under normal conditions. This 
increase in solubility in water is probably due to the 
formation of organized assemblies of hydrotrope 
molecules at critical concentrations. A hydrotrope is 
a compound that solubilizes hydrophobic compounds 
in aqueous solutions. Typically, hydrotropes consist 
of a hydrophilic part and a hydrophobic part (like 
surfactants) but the hydrophobic part is generally too 
small to cause spontaneous self-aggregation. 
Hydrotropes do not have a critical concentration 
above which self-aggregration 'suddenly' starts to 
occur. Instead, some hydrotropes aggregate in a step-
wise self-aggregation process, gradually increasing 
aggregation size. However, many hydrotropes do not 
seem to self-aggregate at all, unless a solubilisate has 
been added. 
 
Itraconazole is a broad spectrum anti-fungal BCS II 
compound and it is a potent triazole antifungal agent 
that is prescribed to patients with fungal infections 
used for the treatment of mycoses. Inhibits the CYP-
450–dependent synthesis of ergosterol, which is a 
vital component of fungal cell membranes. The drug 
may be given orally or intravenously. Itraconazole 
exhibits very poor oral bioavailability owing to its 
insolubility in intestinal fluids. 
Hence objective of present investigation was to 
enhance the solubility of Itraconazole using the 
technique of hydrotropic solubilization and 
formulation, evaluation of hydrotropic solubilization 
based suspension of Itraconazole which will helpful 
to provide stability to formulation and  enhancement 
of bioavailability.  
 
MATERIAL AND METHODS:  
Materials 
Itraconazole was obtained as a gift sample from 
Rachem Pharmaceuticals Ltd, Hyderabad. Trisodium 
citrate, Sodium benzoate, Sodium salicylate, Urea, 
Xanthan gum, Acacia, Sodium alginate, Sachcharin 
sodium, Methyl paraben, Propyl paraben and 
Menthol were obtained from CDH(P) Ltd, New Delhi 
and Sreeplast Pvt Ltd. 
Experimental 
Preparation of hydrotropic solutions 
Different molar concentrations 0.5M, 1M, 2M of the 
hydrotropes (tri sodium citrate, urea, sodium acetate, 
sodium benzoate and sodium salicylates) were 
prepared, by dissolving hydrotropes in triple distilled 
water. 
 
Saturation solubility studies 
Saturation solubility studies were performed in 
triplicate according to the method reported by 
Higuchi and Connors. Excess of pure drug were 
added to 20 ml of different molar solutions of 
hydrotropes in a screwcap tube and shaken in a rotary 
flask shaker at room temperature for 24 hrs. Once 
equilibrium had been achieved, appropriate aliquots 
were withdrawn and filtered through 0.2µ filters. The 
filtrate was suitably diluted with different molar 
solutions of hydrotropes and analyzed at 255 nm by 
UV-visible spectrophotometer. 
 
Preparation of standard stock and calibration curve 
10mg of Itraconazole was dissolved in 10ml of 
methanol until the drug dissolved completely then 
make up the volume to 100 ml with 0.1N Hcl to give 
a concentration of 0.1mg/ml (100µgm/ml).  From the 
above standard solution (100µgm/ml) 1ml was taken 
and diluted to 10ml with 0.1N HCl to give a 
concentration of 0.01mg/ml(10µgm/ml). 
 
From this stock solution aliquots of 0.2,0.4,0.6,0.8 
and 1 ml were pipette out in 10ml volumetric flask 
and the volume was made up to the mark with 0.1N 
HCl to produce concentration of 2, 4, 6, 8 and 10 
µgm/ml respectively. When this solution was scanned 
in the UV range i.e. from 200nm to 800nm λmax was 
found to be 255 nm for Itraconazole in 0.1N HCl as a 
blank in UV-Visible Spectrophotometer (UV-3200 
Lab India). The absorbance (abs) of each 
concentration was measured at 255 nm. 
 
FTIR compatibility studies 
The compatibility between the pure drug and 
excipients was detected by FTIR spectra obtained on 
Bruker FTIR Germany(Alpha T).The potassium 
bromide pellets were prepared on KBr press by 
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grounding the solid powder sample with 100 times 
the quantity of KBr in a mortar. The finely grounded 
powder was then introduced into a stainless steel die 
and was compressed between polished steel anvils at 
a pressure of about 8t/in2. The spectras were recorded 
over the wave number of 8000 to 400cm-1.  
 
Formulation of suspensions 
From the results of saturation solubility it was 
observed that trisodium citrate enhances the 
solubility to the  greater extent than other hydrotropes 
so that formulations were prepared with tri sodium 
citrate hydrotope as a structured vehicle in different 
molar concentrations, xanthan gum, acacia and 
sodium alginate as a suspending agent, sodium 
saccharin as a sweetener and menthol as a flavoring 
agent and negative coolant, methyl paraben and 
propyl paraben as preservatives. 
 
In the preparation initially 40 % of the water was 
taken and then Tri sodium citrate was dissolved in the 
water.  
 
Then suspending agent and preservatives, sweetner 
was added and stirred until to dissolve completely 
and kept for homogenization. To the above solution 
finally drug was added and homogenized for 15 
minutes. Take the remaining water, flavor and 
coloring agent was dissolved and finally make up the 
volume with this water and continue homogenization 
for further 15 minutes.   
 
 
Table 1: Formulation of suspension 
 
 
Evaluation of suspensions 
Appearance of Phases 
The visual inspection was done for the appearance 
dispersed phase and dispersion medium. 
 
Determination of pH 
The pH of the prepared suspensions was measured by 
using ELICO INDIA pH analyser (Model LI612) by 
calibrating with standard buffers  
 
 
 
 
Viscosity Measurement 
The viscosity of the prepared suspensions was 
measured by Brookfield viscometer (Model: DV- 
II+) using spindle S-61 at 100 rpm.    
 
Particle Size measurement  
The particle size of particles in the prepared 
suspensions was measured by optical microscopy 
using a microscope at 100x (10×10) magnification. 
The size of 100 particles were measured and the 
average particle size of was determined. 
 
 
INGREDIENTS F1 F2 F3 F4 F5 F6 F7 F8 F9 
Itraconazole(mg) 250 250 250 250 250 250 250 250 250 
Xanthan gum(mg) 50 50 50  - - - - - - 
Acacia(gm) - - - 1.25 1.25 1.25 - - - 
Sodium alginate(gm) - - - - - - 0.25 0.25 0.25 
Tri sodium citrate(gm) 3.67 7.35 14.7 3.67 7.35 14.7 3.67 7.35 14.7 
Methyl paraben(mg) 25 25 25 25 25 25 25 25 25 
Propyl paraben(mg) 50 50 50 50 50 50 50 50 50 
Sodium saccharin(mg) 37.5 37.5 37.5 37.5 37.5 37.5 37.5 37.5 37.5 
Menthol(mg) 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 
Water(up to ml) 25 25 25 25 25 25 25 25 25 
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Sedimentation volume (F) 
Sedimentation volume (F) is nothing but a ratio of the 
final volume of sediment (Vu) to the original volume 
of sediment (V0) before settling. 50ml of each 
suspension were transferred to 50 ml. measuring 
cylinders and the volume of sediment formed was 
noted after 1 hr, 2 hr, 6hr, 12hr, 24hr ,month. The 
sedimentation volume (F) was calculated using the 
formula- 
                                   F = Vu / Vo 
Redispersibility 
The bottles containing suspension were held up right 
between the fingers and rotated clockwise upside 
down through 1800 in a semicircular path and back in 
the anti-clock wise direction (one cycle). This 
process was repeated continuously until the sediment 
was completely redispersed. 
 
Pourability 
This test is carried out on the phases of suspension 
after mixing to ensure that the final preparation is 
pourable and will not cause any problem during 
filling and during handling by patient. 
 
In -vitro dissolution studies 
In-vitro release studies were carried out using a 
modified USP XXIII dissolution test apparatus (Lab 
India,DS-800). Two objectives in the development of 
in-vitro dissolution tests was to show that  i) Rate of 
drug release is uniform from batch to batch and is the 
same as the release rate from those proven to be 
bioavailable and clinically effective. ii) Release of 
the drug from the suspension is as close as possible 
up to 100%. The dissolution fluid was 900ml of 0.1N 
Hcl buffer at a speed of 50rpm at a temperature of 
370c were used in each test. Samples of dissolution 
medium(3ml) were withdrawn for 5, 10, 20, 30, 
45mins and assayed for Itraconazole by measuring 
absorbance at 255 nm. For all the tests 3ml of the test 
medium were collected at specified time intervals and 
replaced with same volume of 0.1N Hcl buffer used.  
Drug Content estimation 
The content uniformity test is used to ensure that 
every tablet contains the amount of drug substance 
intended with little variation among tablets within a 
batch. 
 
5 ml of suspension was measured accurately and 
transferred in to 100 ml volumetric flask. Sufficient 
quantity of 0.1N Hcl was added to dissolve the drug 
and the volume was made up with0.1N Hcl. From 
this solution, 10 ml was taken and transferred in to a 
100 ml volumetric flask the volume was made up to 
the mark with0.1N Hcl. From this 1ml was drawn in 
to 10ml volumetric flask and the volume was 
adjusted with. 0.1N Hcl the absorbance of the 
solution was measured at 255nm on uv-
spectrophotometer using 0.1N Hcl as blank. 
 
Accelerated stability studies 
Accelerated study of the prepared suspensions was 
performed at 40OC/75% RH for about 3 months as 
per ICH guidelines. The samples were characterized 
for % drug content, in-vitro dissolution and pH. The 
results of the accelerated stability showed the good 
correlation with that of the initial results clearly 
indicating the good stability of the products. 
 
DSC Studies 
The interaction between drug and hydrotrope was 
characterized by differential scanning calorimetry. 
DSC patterns of samples were obtained with 
Shimadzu DSC-50 instrument using vented 
aluminium pans. 
 
XRD Studies 
The interaction between drug and hydrotrope was 
characterized by X-ray diffraction techniques. 
 
RESULTS AND DISCUSSION: 
Standard Calibration curve of Itraconazole 
Table 2: Concentration and absorbance obtained for calibration curve of Itraconazole 
 
 
Concentration (µg/ml) 
Absorbance 
0 0 
2 0.058 
4 0.119 
6 0.179 
8 0.246 
10 0.312 
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Fig. 1: Std graph of Itraconazole 
 
FTIR STUDIES 
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Fig.2: FTIR spectra of  Itraconazole pure drug 
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Fig. 3: FTIR spectra of Itraconazole suspension 
Table 3: FTIR data interpretation 
 
S.NO 
Wave number in formulation (cm-1) Characteristic Wave 
number range (cm-1) 
Bond nature and bond attributed 
Pure drug Optimised 
formulation 
1 3300 3248 3330-3250 N–H stretch 1°, 2° amines, amides 
2 2964 2863 3000-2850 C–H stretch alkanes 
3 1698 1691 1710-1665 C=O stretch α,β–unsaturated 
aldehydes, ketones 
4 1584 1582 1650-1580 N–H bend 1° amines 
5 1552 1481 1550-1475 N–O asymmetric stretch nitro 
compounds 
6 1472 1451 1470-1450 C–H bend alkanes 
7 1042 736 1000-650 =C–H bend alkenes 
8 736 671 900-675 C–H “oop” aromatics 
850–550 (m) C–Cl stretch alkyl 
halides 
 Saturation solubility studies 
From the results of saturation solubility it was observed that trisodium citrate enhances the solubility to the greater 
extent than other hydrotropes so that formulations were prepared by using trisodium citrate hydrotope as a structured 
vehicle. 
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Table 4: Saturation Solubility studies of Itraconazole  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U-Urea, SS-Sodium salicylate, SA-Sodium acetate, TSC-Trisodium citrate, SB-Sodium benzoate. 
 In-vitro drug release studies from the prepared suspensions 
The In-vitro dissolution studies were conducted in 
900ml of 0.1 N Hcl using USP-II apparatus. Samples 
were withdrawn at different time intervals such as 5, 
10, 20, 30 and 45 min. The samples were analyzed 
using UV Visible spectrophotometer at 255 nm 
against reagent blank. 
Table 5: In-vitro drug release profiles of the prepared suspensions 
 
Time(min) F-1 F-2 F-3 F-4 F-5 F-6 F-7 F-8 F-9 
     0 0 0 0 0 0 0 0 0 0 
     5 36.6 37.5 39.3 37.2 38.1 40.2 37.5 38.1 43.5 
    10 63.9 65.1 67.2 65.7 66.9 67.5 66.6 67.8 69.3 
    20 67.5 68.1 72.6 68.7 69.9 73.2 69.3 70.2 77.4 
    30 75.9 77.4 78.6 76.8 78.3 79.2 79.8 80.7 84.3 
    45 78.6 80.7 83.4 79.8 81.3 85.8 83.4 84.6 91.4 
Dissolution rate is increased in the formulations F-7 to F-9 as the concentration of hydrotrope is increased from 0.5 
to 2M respectively. Formulations F-7 shows cumulative drug release is 83.4% at the end of 45min and Formulation 
F-9 shows more than 90% at the end of 45mins. 
 
 
Batch code Solubility(mg/ml) 
U(0.5M) 0.047 
U(1M) 0.0154 
U(2M) 0.1052 
SS(0.5M) 0.0126 
SS(1M) 0.0114 
SS(2M) 0.0108 
SA(0.5) 
0.0252 
SA(1M) 
0.0222 
SA(2M) 
0.0192 
TSC(0.5M) 
0.0489 
TSC(1M) 
0.0599 
TSC(2M) 
0.1066 
SB(0.5) 
0.0142 
SB(1M) 
0.0156 
SB(2M) 
0.0162 
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Invitro Dissolution Studies of all formulations 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4: Dissolution profile of formulations  using Xanthan gum as suspending agent 
      
 
Fig. 5: Dissolution profile of formulations using acacia as suspending agent 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6: Dissolution profile of formulations using Sodium alginate as suspending agent 
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Sedimentation volume determination from the 
prepared suspensions 
The sedimentation volumes of the prepared 
suspensions were determined using 50 ml measuring 
cylinders. The sedimentation volume was checked at 
0,1,2,6,12,and 24 hours. Based on sedimentation 
volume of suspensions made with sodium alginate as 
suspending agent are optimised formulations. (F-7, 
 F-8, F-9). Formulations F-1 to F-3 show poor 
sedimentation volume and formulations F-4 to F-6 
shows formation of hard cake. 
 
Table 6: Sedimentation volume of the prepared suspensions 
                
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Fig. 7: Sedimentation volume of formulations using  Xanthan gum as suspending agent 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8: Sedimentation volume of formulations using  Acacia as suspending agent 
 
 
 
 
 
Fig. 9: Sedimentation volume of formulations using  sodium alginate as suspending agent 
Time(HRS) F-1 F-2 F-3 F-4 F-5 F-6 F-7 F-8 F-9 
0 1 1 1 1 1 1 1 1 1 
1 0.85 0.94 0.96 0.98 1 1 0.98 1 0.96 
2 0.78 0.84 0.91 0.97 0.98 0.96 0.96 0.98 0.94 
6 0.66 0.70 0.84 0.95 0.96 0.95 0.94 0.96 0.90 
12 0.58 0.64 0.72 0.94 0.95 0.94 0.93 0.95 0.87 
24 0.38 0.42 0.54 0.93 0.94 0.92 0.90 0.92 0.84 
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Drug content estimation 
 Assay of the drug in formulations F-1 to F-3 shown 95.6 to 97%, F-4 to F-6 Shown 95.3 to 98% & F-7 to F-9 
shown 96.3 to 99.3% drug content indicates that the drug content remains within the standard limits. 
Table 8: drug content uniformity of nine formulations 
Drug 
content(%CDR) 
FORMULATIONS 
F-1 F-2 F-3 F-4 F-5 F-6 F-7 F-8 F-9 
1) 95.6 96.3 97 95.3 97.3 98 96.3 97.6 99.3 
 
 
Fig.10: Drug content estimation 
 
CONCLUSION: 
Hydrotropic solubilisation technique is used for the 
poorly soluble drug Itraconazole, using various 
hydrotropic agents, results from studies were found 
satisfactory. This was found to be excellent technique 
in the solubility and dissolution enhancement of poor 
water soluble drugs. A suspension dosage form is 
often selected if drug is insoluble in aqueous vehicles 
at the dosage requires and of when the attempts to 
solublize the drug through the use of cosolvents, 
surfactants, and other solubilizing agents would 
compromise the stability or the safety of the product 
or in case of the oral administration its organoleptic 
properties.  It was concluded that aqueous solubility 
of Itraconazole greatly enhance by the synergistic 
effect of different hydrotropic agents . Thus the 
research work overcome the problem of poorly water 
soluble drugs and present methodology can be 
adopted to prepare economical formulation of poorly 
water soluble drug. 
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